Zhang Qiaolei, Li Li, Zhu Lixia, Zhu Jingjing, Yang Xiudi, Zhou De, Zheng Yanglong, Zhu Mingyu, Xie Mixue, Sun Jianai, Li Xueying, Wu Ying, Wei Zhangyue, Xie Wanzhuo, Ye Xiujin
Department of Haematology, Lishui People's Hospital, Lishui, Zhejiang Province, China.
Senior Department of Haematology, The First Affiliated Hospital, Medical School of Zhejiang University, Hangzhou, Zhejiang Province, China.
Swiss Med Wkly. 2018 Sep 23;148:w14641. doi: 10.4414/smw.2018.14641. eCollection 2018 Sep 10.
Haemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome characterised by activation of the mononuclear phagocytic system, and often leads to progressive multiple organ failure. The diagnosis of HLH is made late by most physicians.
To confirm the diagnosis of acquired HLH made in a single-institution series of adult patients with HLH-04 criteria, we applied the HScore and evaluated prognostic factors associated with clinical outcome.
A total of 174 patients with a median age of 51 years (range 17-90) were included. Male/female ratio was 111/63. In 92/174 (52.9%) patients, there were potential haematological diseases (4 acute leukaemia, 1 thrombotic thrombocytopenic purpura, 3 Hodgkin's lymphoma [HL], 17 B-cell non-Hodgkin's lymphoma [NHL], 67 T-cell NHL including 22 natural killer / T-cell NHL [NK/t-cell NHL). Six (3.4%) patients had autoimmune disease and 76 (43.7%) undiagnosed underlying disease. There were 44 (25.3%) patients with Epstein-Barr virus infection, 11 (6.3%) with cytomegalovirus, 1 (0.5%) syphilis, 9 (5.2%) hepatitis B virus and 3 (1.7%) human immunodeficiency virus. More than 95% of patients had hyperferritinaemia, high lactate dehydrogenase, fever and low albumin, whereas 89.1% of patients had bone marrow phagocytosis. By the HScore, 4/174 patients had a >50% and 16/174 patients had a >90% probability of not having HLH. All 174 patients fulfilled more than five of the HLH-04 diagnostic criteria, but 16 of them had a low probability of HLH by the HScore. In a multivariate analysis, lymphopenia and hypofibrinogenaemia were independent prognostic factors for death.
In our study, viral infection was not an independent prognostic factor. NK/T-cell -NHL was associated with worse prognosis compared with B-cell NHL and T-cell NHL (p = 0.036) and similar to other aetiologies.
噬血细胞性淋巴组织细胞增生症(HLH)是一种罕见的临床综合征,其特征为单核吞噬系统激活,常导致进行性多器官功能衰竭。大多数医生对HLH的诊断较晚。
为了确诊依据HLH-04标准在单一机构的成年患者系列中做出的获得性HLH诊断,我们应用了HScore并评估了与临床结局相关的预后因素。
共纳入174例患者,中位年龄51岁(范围17 - 90岁)。男女比例为111/63。在92/174(52.9%)例患者中,存在潜在血液系统疾病(4例急性白血病、1例血栓性血小板减少性紫癜、3例霍奇金淋巴瘤[HL]、17例B细胞非霍奇金淋巴瘤[NHL]、67例T细胞NHL,包括22例自然杀伤/T细胞NHL[NK/t细胞NHL])。6例(3.4%)患者有自身免疫性疾病,76例(43.7%)有未确诊的基础疾病。44例(25.3%)患者有EB病毒感染,11例(6.3%)有巨细胞病毒感染,1例(0.5%)有梅毒,9例(5.2%)有乙型肝炎病毒感染,3例(1.7%)有人免疫缺陷病毒感染。超过95%的患者有高铁蛋白血症、高乳酸脱氢酶、发热和低白蛋白,而89.1%的患者有骨髓吞噬现象。根据HScore,174例患者中有4例(>50%)和16例(>90%)患HLH的可能性较低。所有174例患者均符合HLH-04诊断标准中的五项以上,但其中16例根据HScore患HLH的可能性较低。在多因素分析中,淋巴细胞减少和低纤维蛋白原血症是死亡的独立预后因素。
在我们的研究中,病毒感染不是独立的预后因素。与B细胞NHL和T细胞NHL相比,NK/T细胞NHL的预后较差(p = 0.036),与其他病因相似。